MedPath

doxycycline hyclate

Doxycycline Hyclate Capsules, USP Doxycycline for Oral Suspension, USP Doxycycline Hyclate Tablets, USP

Approved
Approval ID

4164f6b7-5ebd-4f5f-a536-9a37b2e0562c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 7, 2024

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

doxycycline hyclate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50090-5588
Application NumberANDA062500
Product Classification
M
Marketing Category
C73584
G
Generic Name
doxycycline hyclate
Product Specifications
Route of AdministrationORAL
Effective DateOctober 10, 2023
FDA Product Classification

INGREDIENTS (1)

DOXYCYCLINE HYCLATEActive
Quantity: 100 mg in 1 1
Code: 19XTS3T51U
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

doxycycline hyclate - FDA Drug Approval Details